Advertisement

Neurosurgical Review

, Volume 30, Issue 2, pp 155–160 | Cite as

CCM1 gene deletion identified by MLPA in cerebral cavernous malformation

  • Sabine Gaetzner
  • Sonja Stahl
  • Oguzkan Sürücü
  • Anne Schaafhausen
  • Birgit Halliger-Keller
  • Helmut Bertalanffy
  • Ulrich Sure
  • Ute Felbor
Case Report

Abstract

Familial cerebral cavernous malformations (CCMs) occur with a frequency of 1 in 2000 and may cause recurrent headaches, seizures, and hemorrhagic stroke. Exon-scanning-based methods have identified intragenic mutations in three genes, CCM1, CCM2, and CCM3, in about 70% of familial CCM. To date, only two large CCM2 and a single large CCM3 deletion have been published. In addition to direct sequencing of all three CCM genes, we applied a newly developed multiplex ligation-dependent probe amplification gene dosage assay (MLPA) designed to detect genomic CCM1–3 deletions/duplications. Direct sequencing did not reveal a mutation in the index case who presented with multiple CCMs that had caused a generalized tonic-clonic seizure with Todd’s paralysis and headaches at the age of 5. In contrast, MLPA analyses detected a large deletion involving the entire CCM1 coding region in the proband and further affected members of this German CCM family. The MLPA results were corroborated by analyses of single nucleotide polymorphisms (SNPs) within the CCM1 gene. Thus, we here present the first report on a CCM1 gene deletion. Our results confirm a loss-of-function mutation mechanism for CCM1 and demonstrate that the use of MLPA enables a higher CCM mutation detection rate which is crucial for predictive testing of at-risk relatives.

Keywords

Vascular malformations Cerebral cavernous malformation Genetics MLPA Deletion 

Notes

Acknowledgements

The authors thank the patients and their family for their cooperation and MRC Holland for developing the MLPA kits. Ute Felbor receives an Emmy Noether-grant from the Deutsche Forschungsgemeinschaft (Fe 432/6-5) and Sonja Stahl a stipend from the Graduiertenkolleg 1048.

References

  1. 1.
    Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76:42–51PubMedCrossRefGoogle Scholar
  2. 2.
    Cavé-Riant F, Denier C, Labauge P, Cecillon M, Maciazek J, Joutel A, Laberge-Le Couteulx S, Tournier-Lasserve E (2002) Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations. Eur J Hum Genet 10:733–740PubMedCrossRefGoogle Scholar
  3. 3.
    Damgaard D, Nissen PH, Jensen LG, Nielsen GG, Stenderup A, Larsen ML, Faergeman O (2005) Detection of large deletions in the LDL receptor gene with quantitative PCR methods. BMC Med Genet 6:15PubMedCrossRefGoogle Scholar
  4. 4.
    Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau JJ, Nivelon-Chevallier A, Parker F, Redondo AM, Scarabin JM, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74:326–337PubMedCrossRefGoogle Scholar
  5. 5.
    Guclu B, Ozturk AK, Pricola KL, Bilguvar K, Shin D, O’Roak BJ, Gunel M (2005) Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery 57:1008–1013PubMedCrossRefGoogle Scholar
  6. 6.
    Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189–193PubMedCrossRefGoogle Scholar
  7. 7.
    Lalic T, Vossen RH, Coffa J, Schouten JP, Guc-Scekic M, Radivojevic D, Djurisic M, Breuning MH, White SJ, den Dunnen JT (2005) Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 13:1231–1234PubMedCrossRefGoogle Scholar
  8. 8.
    Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459–1464PubMedCrossRefGoogle Scholar
  9. 9.
    Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, Cannella M, Maglione V, Ptacek L, Johnson EW, Marchuk DA (2006) Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 27:118PubMedCrossRefGoogle Scholar
  10. 10.
    Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57PubMedCrossRefGoogle Scholar
  11. 11.
    Sürücü O, Sure U, Gaetzner S, Stahl S, Benes L, Bertalanffy H, Felbor U (2006) Clinical impact of CCM mutation detection in familial cavernous angioma. Childs Nerv Syst 22:1461–1464CrossRefGoogle Scholar
  12. 12.
    Verlaan DJ, Roussel J, Laurent SB, Elger CE, Siegel AM, Rouleau GA (2005) CCM3 mutations are uncommon in cerebral cavernous malformations. Neurology 65:1982–1983PubMedCrossRefGoogle Scholar
  13. 13.
    Verlaan DJ, Siegel AM, Rouleau GA (2002) Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation. Am J Hum Genet 70:1564–1567PubMedCrossRefGoogle Scholar
  14. 14.
    Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, Legius E, Callens T, Beiglbock H, Maertens O, Messiaen L (2006) Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 45:265–276PubMedCrossRefGoogle Scholar
  15. 15.
    Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14:2521–2531PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Sabine Gaetzner
    • 1
  • Sonja Stahl
    • 1
  • Oguzkan Sürücü
    • 2
  • Anne Schaafhausen
    • 1
  • Birgit Halliger-Keller
    • 1
  • Helmut Bertalanffy
    • 2
  • Ulrich Sure
    • 2
  • Ute Felbor
    • 1
  1. 1.Department of Human GeneticsUniversity of WürzburgWürzburgGermany
  2. 2.Department of NeurosurgeryUniversity of MarburgMarburgGermany

Personalised recommendations